Device product
TheraSphere(R) YTTRIUM-90 CLASS MICROSPHERE INJECTION TheraSphere¿ is indicated for radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable HCC who can have placement of appropriately positioned hepatic arterial catheters.
Z-0078-2017
Product summary
- Event
- Event 75350
- Status
- Terminated
- Classification
- Class II
- Quantity
- 64 doses
- Official record key
device-enforcement:Z-0078-2017
Official wording
Reason: One mislabeled dose of TheraSphere¿ Y-90 Glass Microspheres, which was shipped to Hong Kong (total radioactivity incorrect). The product ws labeled as 10 GBq and the actual does was 5 GBq.
Code information: Lot 1599211, Expiry Date: 18SEP2015 (12 days after calibration)
Distribution pattern: Worldwide Distribution - US to CA, FL, IL, WI, IN, OR, PA, MA, NY, KY, TX, MI, MD, NV, WA, OH, MN, and Internationally to Germany, Turkey, Hong Kong, Italy, Portugal
Derived failure modes
-
Labeling or packaging
mislabeled